FDA issued a Warning Letter to Delta Pharma, Inc. on 12/9/2014 as a result of this inspection.
483 Delta Pharma Oct 2013

483 Delta Pharma Oct 2013

Zada Giles FDA, Brandon Heitmeier FDA$119.00 - Available Now

FDA investigators audited the Delta Pharma - Ripley, MS, United States facility and issued 9 inspectional observations (via FDA 483) on 02 Oct 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 9
  • Inspection end: 02 Oct 2013
  • Location: Ripley, United States
  • FEI: 3004034796
Add To Cart